About us

Home > Company Introduction

Wuhan Life Origin Biotech Joint Stock Co., Ltd. is a high-tech enterprise specialized in the R&D, production and sales of In Vitro diagnostic reagent for clinical medicine. The company registered capital is RMB 13 million. It is located in the National High-tech Development Zone-Wuhan Optics Valley of China.
 
The company currently employs over 300 peoples, among them more than 30 are Masters and PhDs. It has built 1,000 square meters purification plant in accordance with the standards of pharmaceutical GMP and 5,600 square meters "Clinical In Vitro Diagnostic Reagents R&D Center". It has the national top two technology platforms: IVD raw materials development and related product & technical service platform and Latex enhanced product R&D platform to form a complete industrial chain from IVD raw materials R&D to the IVD reagent sales. Life Origin has become one of the very few IVD reagents companies that have a complete IVD reagents industrial chain in China.
 
At present, the company has nearly 20 national patents, won multiple Wuhan City Product independent Innovation Prizes, National East Lake New Technology Development Zone bio-industry Special Project and the National Ministry of Science and Technology innovation fund for technology-based key enterprise.
 
In 2011 Life Origin wholly acquired Wuhan Huamei Biotech Co., Ltd., the domestic well-known scientific research reagents and IVD raw material manufacturer. Wuhan Huamei Biotech Co., Ltd. is a high-tech enterprise specialized in research reagents and IVD raw materials. Its products are sold in more than 90 countries worldwide, China's Optics Valley forefront bio-export enterprise, was referenced as a "Gazelle Enterprise" for many successive years; listed in the "Hubei province Science and Technology Key Enterprise Growth Roadmap Plan; referenced as "National High-tech Enterprise" by the Ministry of Science and Technology of China; Member of the East Lake High-tech Zone "3551 Optics Valley Talents Program"; become the only company in Hubei Province to award “2012-Deloitte Hi-tech & Fast Growing Top 50 Enterprise in China and top 500 Enterprise in Asia-Pacific”.
 
In June 2012, Wuhan Huamei Biotech. Co., Ltd. and Wuhan Jinlisheng Medical Devices Co., Ltd. have been incorporated into Life Origin. August 2012, Life Origin has officially launched its listing. Accompany the implementation of the concept “Building the most perfect after-sales platform service in diagnostic reagents field”, collectivize management and deep marketing strategy have become the blueprint development next step of Life Origin.
 
For its long-term development, Life Origin adheres to the developing thought “People-oriented and efforts for human health”, relies on specialization and innovation, strives to build an outstanding brand enterprise in the field of in vitro diagnostics reagents.